Drug Profile


Alternative Names: TAK-363; TRK-130

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Takeda; Toray
  • Class Urologics
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Overactive bladder
  • Discontinued Urinary frequency; Urinary incontinence

Most Recent Events

  • 17 May 2016 Chemical information added
  • 11 Apr 2005 Preclinical trials in Urinary frequency in USA (unspecified route)
  • 11 Apr 2005 Preclinical trials in Urinary incontinence in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top